Role of DNA mismatch repair in apoptotic responses to therapeutic agents
- 1 January 2004
- journal article
- review article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 44 (4) , 249-264
Abstract
Deficiencies in DNA mismatch repair (MMR) have been found in both hereditary cancer (i.e., hereditary nonpolyposis colorectal cancer) and sporadic cancers of various tissues. In addition to its primary roles in the correction of DNA replication errors and suppression of recombination, research in the last 10 years has shown that MMR is involved in many other processes, such as interaction with other DNA repair pathways, cell cycle checkpoint regulation, and apoptosis. Indeed, a cell's MMR status can influence its response to a wide variety of chemotherapeutic agents, such as temozolomide (and many other methylating agents), 6‐thioguanine, cisplatin, ionizing radiation, etoposide, and 5‐fluorouracil. For this reason, identification of a tumor's MMR deficiency (as indicated by the presence of microsatellite instability) is being utilized more and more as a prognostic indicator in the clinic. Here, we describe the basic mechanisms of MMR and apoptosis and investigate the literature examining the influence of MMR status on the apoptotic response following treatment with various therapeutic agents. Furthermore, using isogenic MMR‐deficient (HCT116) and MMR‐proficient (HCT116 3‐6) cells, we demonstrate that there is no enhanced apoptosis in MMR‐proficient cells following treatment with 5‐fluoro‐2′‐deoxyuridine. In fact, apoptosis accounts for only a small portion of the induced cell death response. Environ. Mol. Mutagen. 44:249–264, 2004.Keywords
This publication has 163 references indexed in Scilit:
- “Recruitment Signals” from Apoptotic CellsCell, 2003
- Renewing the debate over the p53 apoptotic responseCell Death & Differentiation, 2003
- The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phaseOncogene, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Mismatch repair in correction of replication errors and processing of DNA damageJournal of Cellular Physiology, 2001
- Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasiaOncogene, 2001
- Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S6-MethylthioguanineBiochemistry, 1997
- Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancerNature, 1994
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993